Okumura K, Suzuki K, Tsuge I, Moribe K, Kimura T, Motai H, Baba S
Department of Otolaryngology, Nagoya City University Medical School, Japan.
Acta Otolaryngol Suppl. 1996;525:142-5.
The therapeutic results in 40 newly diagnosed patients with tongue cancer treated in our department between January 1981 and December 1991 were evaluated. The 5-year survival rate of the 40 patients was 61.4%, and the cumulative 10-year survival rate was 53.7%. The 5-year survival rate in 15 patients who were in Stage I or Stage II was poor at 66.5%, and recurrence by metastasis to cervical lymph nodes was observed in 6 out of 8 patients who underwent surgery alone as the primary treatment.
对1981年1月至1991年12月间在我科接受治疗的40例新诊断舌癌患者的治疗结果进行了评估。40例患者的5年生存率为61.4%，累积10年生存率为53.7%。15例I期或II期患者的5年生存率较差，为66.5%，在8例仅接受手术作为主要治疗的患者中，有6例出现了颈部淋巴结转移复发。
